about
Mitochondrial localization of vitamin D receptor in human platelets and differentiated megakaryocytesZoledronic acid restores doxorubicin chemosensitivity and immunogenic cell death in multidrug-resistant human cancer cellsIloprost modulates the immune response in systemic sclerosis.Mitochondrial translocation of vitamin D receptor is mediated by the permeability transition pore in human keratinocyte cell line.Human protein cluster analysis using amino acid frequencies.Middle T antigen-transformed endothelial cells exhibit an increased activity of nitric oxide synthase.Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression.Glioblastoma cancer stem cells: heterogeneity, microenvironment and related therapeutic strategies.The role of circulating bone cell precursors in fracture healing.Digoxin and ouabain induce the efflux of cholesterol via liver X receptor signalling and the synthesis of ATP in cardiomyocytes.Long-term exposure to dehydroepiandrosterone affects the transcriptional activity of the glucocorticoid receptor.Statins revert doxorubicin resistance via nitric oxide in malignant mesothelioma.The biochemistry of gene therapy for AIDS.Calcium blood level modulates endogenous nitric oxide action: effects of parathroidectomy in patients with hyperparathyroidism.Platelet cyclic GMP levels in unstable angina and myocardial infarction.Transdermal oestradiol replacement therapy enhances platelet constitutive nitric oxide synthase activity in postmenopausal women with type 2 diabetes mellitus.Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis.Alendronate reduces osteoclast precursors in osteoporosis.Serum citrate levels, haptoglobin haplotypes and transferrin receptor (CD71) in patients with HIV-1 infection.Infectious and inflammatory stimuli decrease endothelial nitric oxide synthase activity in vitro.Metabolism of pyridoxal phosphate in the liver of hypo- and hyperthyroid rats.Spontaneous osteoclast formation from peripheral blood mononuclear cells in postmenopausal osteoporosis.Digoxin and ouabain induce P-glycoprotein by activating calmodulin kinase II and hypoxia-inducible factor-1alpha in human colon cancer cells.Digoxin and ouabain increase the synthesis of cholesterol in human liver cells.Glutathione levels in patients with erectile dysfunction, with or without diabetes mellitus.Risedronate reduces osteoclast precursors and cytokine production in postmenopausal osteoporotic women.Non-linear model of cancer growth and metastasis: a limiting nutrient as a major determinant of tumor shape and diffusion.Improved extraction and determination of some glycolytic enzymes in the human erythrocyte.Bone and bone marrow pro-osteoclastogenic cytokines are up-regulated in osteoporosis fragility fractures.Characterization of a new compound, S35b, as a guanylate cyclase activator in human plateletsNitrovasodilators inhibit thrombin-induced platelet-activating factor synthesis in human endothelial cells2,3-Diphosphoglycerate synthesis by human white ghostsLocal interaction simulation approach for the response of the vascular system to metabolic changes of cell behaviorIron metabolism markers and haptoglobin phenotypes in susceptibility to HSV-1 or/and HSV-2 lesion relapsesImmune system and bone metabolism: Does thymectomy influence postmenopausal bone loss in humans?A novel composition for in vitro and in vivo regeneration of skin and connective tissuesCorrelation between nitric oxide synthase activity and reduced glutathione level in human and murine endothelial cells
P50
Q28472571-945C9032-F6AC-46DD-8CBF-EF7B82194F71Q28486174-B3D63B8C-77D7-4CFA-AFC5-8933BB378CD4Q33772202-27BF38E1-2DE8-4E8E-8F11-5FBEFA6D2768Q34563407-FBA0CA52-67C3-44F2-A20A-6D6FFDA1A78AQ34672778-3C81758B-5FE2-4C70-B38D-FBF761151324Q36364302-2DEBF101-FE11-4468-A30C-D4EE8396D98FQ37230670-0E473D44-B6CF-449D-8299-D39F70C64828Q37763908-590E5395-6994-4590-B7CF-A6094FC5F3B9Q38344864-7F4831FF-E822-4D36-B1B0-A03D080A48C3Q39305936-E594688E-5064-4AB2-8E39-2D701436B780Q40214595-2EBF7158-5EA9-4898-A5D2-2CF0C9C15BD7Q40322360-D08BDF19-3575-40AF-A9C3-F652511481B9Q40854213-FE9B9CB8-03AE-4280-88BE-F0B9C8837D35Q42452784-738DC08E-1D2E-459A-86E4-9FCE92012885Q42525023-EF187552-B8C1-443F-AB07-B07CF4B49717Q42525318-5B609E06-66C2-4839-A3AA-AEAFC12E2015Q42526719-80821400-C421-4F7C-8995-FB9FED885FF7Q43233359-AA5D138C-C0E4-4C34-BD46-91948E99B57AQ43998447-F474D013-6343-4519-A36F-BD64CB9140D0Q44642150-0B735DEA-95B2-4788-993B-512F04674396Q44796916-BFC602B5-BC83-41EF-A262-7819D1BB9081Q45195886-76B2DB02-65C7-48B4-8A51-52665E0F660DQ45914386-15D1EB71-3704-4202-9167-B3AD6DA6B2C1Q46087596-2DAC777C-D728-4E14-8EB4-40247BBC4327Q46504484-E561FE4C-C65C-4FAE-B2B3-AB782DD705C4Q46926139-E6B1367D-6E1D-47D2-B8AB-210AEF9CB897Q52081807-34DAAF3B-0B54-4203-AE44-D470E144F5EAQ53859353-AA9C76A1-A0C2-472F-8D1A-3AFFD76403D3Q54399590-35944C70-C0DB-4E1A-B6CE-2B4CD11F6BDCQ59545828-3CB8E213-9F5C-4D8E-9D6B-D14EE15A60A5Q67493397-23B7C5A7-435B-47BA-B6BB-5385097F2B43Q68705630-E719FC84-9CD6-4820-B053-13D3B7F221B3Q73756840-9DF0444D-A9C6-4D60-91C9-F631C2FC3F39Q82559607-96699C67-3837-46A5-BA70-5047C0897F31Q83322481-86664982-9334-4429-B89C-754BA55695B6Q83859500-9ECBFE27-468F-48C7-8770-72D87E5932FFQ86624567-6000F9B2-10C6-4D4B-B04C-155D5556B193
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-2143-8901
@en
name
Gian Piero Pescarmona
@an
Gian Piero Pescarmona
@ast
Gian Piero Pescarmona
@ca
Gian Piero Pescarmona
@da
Gian Piero Pescarmona
@de
Gian Piero Pescarmona
@en
Gian Piero Pescarmona
@es
Gian Piero Pescarmona
@eu
Gian Piero Pescarmona
@fr
Gian Piero Pescarmona
@gl
type
label
Gian Piero Pescarmona
@an
Gian Piero Pescarmona
@ast
Gian Piero Pescarmona
@ca
Gian Piero Pescarmona
@da
Gian Piero Pescarmona
@de
Gian Piero Pescarmona
@en
Gian Piero Pescarmona
@es
Gian Piero Pescarmona
@eu
Gian Piero Pescarmona
@fr
Gian Piero Pescarmona
@gl
prefLabel
Gian Piero Pescarmona
@an
Gian Piero Pescarmona
@ast
Gian Piero Pescarmona
@ca
Gian Piero Pescarmona
@da
Gian Piero Pescarmona
@de
Gian Piero Pescarmona
@en
Gian Piero Pescarmona
@es
Gian Piero Pescarmona
@eu
Gian Piero Pescarmona
@fr
Gian Piero Pescarmona
@gl
P106
P1153
7004344372
P21
P31
P496
0000-0003-2143-8901